The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
April 19th 2024
Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases
Study: Bariatric Surgery Reduces Cancer Risk for Patients With NAFLD
April 5th 2021Bariatric surgery can significantly reduce the risk of cancer—and especially obesity-related cancers—by as much as half in individuals with severe obesity and nonalcoholic fatty liver disease (NAFLD), according to a study by researchers at Rutgers Robert Wood Johnson Medical School's Center for Liver Diseases and Liver Masses.
Read More
X-ray Study Explores Potential of Hepatitis C Drugs to Treat COVID-19
November 19th 2020The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.
Read More
Coordinated Approach Needed to Increase Follow-Up Care After Rapid HIV, HCV Testing
September 14th 2020Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.
Read More